4. FOXO4-DRI Peptide: Targeting Senescent Cells

The FOXO4-DRI peptide is a pioneering anti-aging innovation, introduced in 2025, that precisely induces apoptosis in senescent cells while sparing healthy ones. This targeted approach holds promise for reversing tissue aging and restoring youthful function. As reported by Nature, FOXO4-DRI represents a significant leap forward in the realm of precision senolytic therapies.